Compared with opioids, other high impact drug classes like topicals, compound kits, combo packs, and specialty medications, represent proportionately low volume. However, they can be associated with exponentially significant costs. Recognizing the trends related to such cost drivers can help promote clinically-appropriate savings. Watch the video blog to learn more.
States adapting new policies and strategies to overcome access-to-care challenges The COVID-19 pandemic has dramatically changed the heal
March 31, 2020—On Tuesday, the Automotive Service Association hosted a webinar on how to effectively handle the trickle-down effect of the COVID-19
The Montana Department of Labor and Industry is asking insurers and employers to delay the application of the drug formulary for legacy claims unti
Late Tuesday evening, March 31, 2020, the New York State Workers' Compensation Board released new guidance on how to handle prior authorization req